Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) Gross Margin (2018 - 2025)

Viemed Healthcare's Gross Margin history spans 8 years, with the latest figure at 57.89% for Q4 2025.

  • For Q4 2025, Gross Margin fell 165.0% year-over-year to 57.89%; the TTM value through Dec 2025 reached 57.52%, down 188.0%, while the annual FY2025 figure was 57.52%, 188.0% down from the prior year.
  • Gross Margin reached 57.89% in Q4 2025 per VMD's latest filing, up from 57.49% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 64.33% in Q2 2021 to a low of 56.28% in Q1 2025.
  • Average Gross Margin over 5 years is 60.43%, with a median of 60.62% recorded in 2022.
  • Peak YoY movement for Gross Margin: soared 461bps in 2021, then crashed -375bps in 2024.
  • A 5-year view of Gross Margin shows it stood at 61.52% in 2021, then dropped by -1bps to 61.04% in 2022, then increased by 4bps to 63.29% in 2023, then dropped by -6bps to 59.54% in 2024, then dropped by -3bps to 57.89% in 2025.
  • Per Business Quant, the three most recent readings for VMD's Gross Margin are 57.89% (Q4 2025), 57.49% (Q3 2025), and 58.25% (Q2 2025).